Vir Biotechnology, Inc. Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vir Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vir Biotechnology, Inc. for September 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 28 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 3,700 | 5,661 | 463,385 | |
Sep 28 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 3,700 | 5,661 | 23,700 | 20 K to 23.7 K (+18.50 %) |
Sep 23 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 3,805 | 5,822 | 467,085 | |
Sep 23 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 31.71 | 3,805 | 120,638 | 20,000 | 23.8 K to 20 K (-15.98 %) |
Sep 23 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 3,805 | 5,822 | 23,805 | 20 K to 23.8 K (+19.03 %) |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 5.18 | 2,315 | 11,980 | 69,444 | |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.53 | 465 | 711 | 110,646 | |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.58 | 9,720 | 15,309 | 53,242 | |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 31.92 | 5,000 | 159,591 | 29,777 | 34.8 K to 29.8 K (-14.38 %) |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 31.88 | 7,500 | 239,103 | 34,777 | 42.3 K to 34.8 K (-17.74 %) |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 5.18 | 2,315 | 11,980 | 42,277 | 40 K to 42.3 K (+5.79 %) |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.53 | 465 | 711 | 39,962 | 39.5 K to 40 K (+1.18 %) |
Sep 18 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.58 | 9,720 | 15,309 | 39,497 | 29.8 K to 39.5 K (+32.64 %) |
Sep 10 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 3,805 | 5,822 | 470,890 | |
Sep 10 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 29.98 | 2,340 | 70,148 | 20,000 | 22.3 K to 20 K (-10.47 %) |
Sep 10 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 30.00 | 1,465 | 43,950 | 22,340 | 23.8 K to 22.3 K (-6.15 %) |
Sep 10 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 3,805 | 5,822 | 23,805 | 20 K to 23.8 K (+19.03 %) |
Sep 10 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 25,560 | 39,107 | 474,695 | |
Sep 10 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 42.92 | 5,560 | 238,632 | 20,000 | 25.6 K to 20 K (-21.75 %) |
Sep 10 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 25,560 | 39,107 | 25,560 | 0 to 25.6 K |
Sep 03 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.58 | 12,500 | 19,688 | 62,962 | |
Sep 03 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 32.91 | 5,000 | 164,537 | 29,777 | 34.8 K to 29.8 K (-14.38 %) |
Sep 03 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 32.88 | 7,500 | 246,622 | 34,777 | 42.3 K to 34.8 K (-17.74 %) |
Sep 03 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.58 | 12,500 | 19,688 | 42,277 | 29.8 K to 42.3 K (+41.98 %) |
Sep 03 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Option Exercise | M | 1.58 | 6,943 | 10,935 | 53,241 | |
Sep 03 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Sell | S | 39.15 | 6,943 | 271,796 | 222,222 | 229.2 K to 222.2 K (-3.03 %) |
Sep 03 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Buy | M | 1.58 | 6,943 | 10,935 | 229,165 | 222.2 K to 229.2 K (+3.12 %) |
Sep 01 2020 | VIR | Vir Biotechnology, ... | Napolitano Janet | Director | Option Exercise | A | 41.64 | 33,000 | 1,374,120 | 33,000 |